Q1 Earnings Estimate for CLB Issued By Zacks Research

Core Laboratories Inc. (NYSE:CLB) – Equities researchers at Zacks Research issued their Q1 2025 EPS estimates for Core Laboratories in a research note issued on Wednesday, March 26th. Zacks Research analyst T. Saha forecasts that the oil and gas company will earn $0.15 per share for the quarter. The consensus estimate for Core Laboratories’ current full-year earnings is $0.96 per share. Zacks Research also issued estimates for Core Laboratories’ Q3 2025 earnings at $0.24 EPS, Q4 2025 earnings at $0.24 EPS, FY2025 earnings at $0.83 EPS, Q2 2026 earnings at $0.24 EPS, Q3 2026 earnings at $0.28 EPS and FY2026 earnings at $1.04 EPS.

Separately, Citigroup raised Core Laboratories from a “sell” rating to a “neutral” rating and raised their target price for the stock from $15.00 to $16.00 in a research report on Wednesday, March 12th. One research analyst has rated the stock with a sell rating and four have issued a hold rating to the company. According to MarketBeat, the stock has an average rating of “Hold” and an average target price of $17.50.

Core Laboratories Price Performance

Shares of CLB opened at $15.00 on Monday. The firm has a fifty day simple moving average of $16.23 and a two-hundred day simple moving average of $18.08. The firm has a market cap of $702.17 million, a PE ratio of 22.72, a P/E/G ratio of 0.99 and a beta of 2.38. The company has a current ratio of 2.32, a quick ratio of 1.71 and a debt-to-equity ratio of 0.49. Core Laboratories has a 1-year low of $12.95 and a 1-year high of $25.13.

Core Laboratories (NYSE:CLB) last announced its quarterly earnings data on Wednesday, January 29th. The oil and gas company reported $0.23 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.23. Core Laboratories had a net margin of 5.99% and a return on equity of 16.24%.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in the stock. State Street Corp increased its holdings in Core Laboratories by 2.9% in the 3rd quarter. State Street Corp now owns 1,975,016 shares of the oil and gas company’s stock worth $36,597,000 after acquiring an additional 56,187 shares in the last quarter. Geode Capital Management LLC boosted its position in shares of Core Laboratories by 0.7% in the third quarter. Geode Capital Management LLC now owns 1,053,204 shares of the oil and gas company’s stock worth $19,521,000 after purchasing an additional 7,721 shares during the period. Boston Trust Walden Corp increased its stake in shares of Core Laboratories by 2.7% in the fourth quarter. Boston Trust Walden Corp now owns 617,336 shares of the oil and gas company’s stock worth $10,686,000 after purchasing an additional 16,503 shares in the last quarter. Amundi lifted its stake in shares of Core Laboratories by 194.8% during the 4th quarter. Amundi now owns 32,968 shares of the oil and gas company’s stock valued at $600,000 after buying an additional 21,783 shares in the last quarter. Finally, Barclays PLC boosted its holdings in Core Laboratories by 288.2% in the 3rd quarter. Barclays PLC now owns 83,570 shares of the oil and gas company’s stock worth $1,549,000 after buying an additional 62,042 shares during the period. Institutional investors own 97.81% of the company’s stock.

Core Laboratories Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, March 3rd. Shareholders of record on Monday, February 10th were issued a dividend of $0.01 per share. This represents a $0.04 annualized dividend and a yield of 0.27%. The ex-dividend date of this dividend was Monday, February 10th. Core Laboratories’s dividend payout ratio is presently 6.06%.

Core Laboratories Company Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.